يعرض 1 - 10 نتائج من 38 نتيجة بحث عن '"Guldbrandsen, Nina"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Nielsen , L K , Schjesvold , F , Möller , S , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , Abildgaard , N , Gregersen , H & King , M T 2024 , ' Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma : a randomized phase 2 trial by the Nordic Myeloma Study Group ' , Journal of Patient-Reported Outcomes , vol. 8 , no. 1 , 15 . https://doi.org/10.1186/s41687-024-00691-2Test

  2. 2
    مؤتمر
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
  6. 6
    مؤتمر

    المصدر: Nielsen , L K , Möller , S , Schjesvold , F , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , King , M , Abildgaard , N & Gregersen , H 2023 , ' Quality adjusted progression-free-period of Carfilzomib-dexamethasone maintenance therapy for patients with multiple myeloma treated for first relapse – findings from a Nordic Myeloma Study Group randomized phase II trial. ' , Dansk Kræftforskningsdage , Odense , Denmark , 31/08/2023 - 01/09/2023 .

  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    مؤتمر

    المصدر: Eshoj , H R , Nielsen , L K , Schjesvold , F , Abildgaard , N , Nahi , H , Andersen , N F , Vangsted , A J , Helleberg , C , Frolund , U C , Axelsson , P , Stromberg , O , Blimark , C , Carlson , K , Waage , A , Remes , K , Peceliunas , V , Guldbrandsen , N , Hansson , M & Gregersen , H 2018 , ' Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and ....

  10. 10

    المصدر: Eshoj, H R, Nielsen, L K, Schjesvold, F, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Helleberg, C, Frolund, U C, Axelsson, P, Stromberg, O, Blimark, C, Carlson, K, Waage, A, Remes, K, Peceliunas, V, Guldbrandsen, N, Hansson, M & Gregersen, H 2018, ' Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation : data from a Nordic phase II trial ', Quality of Life Research, vol. 27, no. Suppl. 1, 2048, pp. S137 . https://doi.org/10.1007/s11136-018-1946-9Test
    University of Southern Denmark
    Eshoj, H R, Nielsen, L K, Schjesvold, F, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Helleberg, C, Frolund, U C, Axelsson, P, Stromberg, O, Blimark, C, Carlson, K, Waage, A, Remes, K, Peceliunas, V, Guldbrandsen, N, Hansson, M & Gregersen, H 2018, ' Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial ', Quality of Life Research, vol. 27, no. 1, 2048, pp. S137 . < https://doi.org/10.1007/s11136-018-1946-9Test >
    Publons